National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology Westmead Hospital Laboratory – Institute of Clinical Pathology and Medical Research
Accreditation No.
2154
Site No.
2147
Date of Accreditation
05 Jan 1987
Address
166-174 Hawkesbury Road
Westmead, NSW 2145
Australia
Contact
Dr Susan Weston P: +61 (02) 88906325
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
B5b Respiratory Ward
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Glucose; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Birth Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
Cardio thoracic Intensive Care
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Cardiology Department (K12)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Center for Newborn Care
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Core Diagnostics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol; Paracetamol (acetaminophen) |
| Urine | Amphetamines; Benzodiazepines; Cannabis; Cocaine; Methadone; Opiates | |
| 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Tacrolimus |
| Plasma; Serum | Amikacin; Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Phenobarbital; Phenytoin (dilantin); Salicylate; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; Prostate specific antigen (PSA) fractions and derived index; Thyroglobulin; α-Fetoprotein (AFP) |
| Plasma; Serum; Urine | β2-Microglobulin (B2M) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Adrenocorticotropic hormone (ACTH) |
| Plasma; Serum | Aldosterone; Insulin-like growth factor 1 (IGF-1, somatomedin C); Renin | |
| Adrenocorticotropic hormone (ACTH); C-peptide; Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Growth hormone; Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone - Total | ||
| Plasma; Urine | Aldosterone | |
| Serum | Growth hormone | |
| 17α-Hydroxyprogesterone | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Glycated haemoglobin (HbA1c) | ||
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin T |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | Apolipoprotein A1; Apolipoprotein B; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Bile acids - Quantitative; Caeruloplasmin; Haptoglobins; α1-Antitrypsin |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Bilirubin; Haemoglobin (Hb); Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Ferritin; Globulin; Glucose; HDL - Quantitation; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Urine | Osmolality | |
| Serum | Angiotensin converting enzyme (ACE) | |
| Urine | Albumin; Albumin/creatinine ratio (ACR); Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Total iron-binding capacity (TIBC); Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH |
| Pleural fluid | pH | |
| Chemical pathology - Quantitation of vitamin B markers | Plasma; Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Plasma; Serum | Zinc |
| Urine | Iodine | |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Urine | Haemosiderin |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Mean platelet volume (MPV); Morphology; Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Reticulocytes |
| Cerebrospinal fluid (CSF); Fluids | Morphology | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; Prothrombin time (PT); Thrombin time (TT) |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO); Rheumatoid factor |
| Serum | Anti-cyclic citrullinated peptide antibodies (CCP); Anti-thyrotropin receptor antibodies (TSHR) | |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) |
Department of Anaesthesia
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
| Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH | ||
| Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Diabetic Education Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency COVID Ward K5 Clinical Acute Services Building
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Emergency Department – Clinical Acute Services Building K1
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Deoxyhaemoglobin (HHb); Glucose; Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
| Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH | ||
| Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH | ||
| Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Bone marrow | Chromosomal rearrangement |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH) |
| Examination of haemoglobin H (HbH); Haemoglobin A (HbA) - Quantitation; Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation; Haemoglobin H (HbH) inclusions | ||
| Haematology - Full blood examination | Blood | Leucocyte count (white blood cell count, WBCC) |
| Bone marrow | Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| Platelet function (PFA) | ||
| Plasma | Activated protein C (APC) resistance; Collagen binding activity; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII; Heparin assay; Lupus anticoagulant; Plasminogen activator inhibitor; Protein C and protein S; Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | |
| Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Rivaroxaban; Anti-Xa activity - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; Danaparoid sodium | ||
| ADAMTS-13 activity; ADAMTS-13 inhibitor | ||
| Von Willebrand factor (vWF) multimers | ||
| Plasma; Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Haematology - Investigation of haemolysis | Serum | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood; Plasma; Serum | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma; Serum | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Blood; Plasma; Serum | Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Antibody titration | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products; Plasma | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF) | Assessment of lymphoid cell populations; Leukaemia screen; Lymphoma screen; Memory B cell subsets; Myeloma screen; Paroxysmal nocturnal haemoglobinuria (PNH) surface markers |
| Blood | CD16; CD19; CD3; CD45; CD56; CD8 | |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-cardiolipin antibodies (ACA); Anti-β2-glycoprotein-I antibodies |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood; Extracted DNA | Gilberts disease |
| Factor V Leiden; Haemochromatosis; Prothrombin variant; Thiopurine methyltransferase (TPMT); α1-Antitrypsin | ||
| Molecular genetics - DNA extraction | Blood; Bone marrow; Buccal swabs; Formalin-fixed paraffin-embedded (FFPE) tissues; Saliva; Tissues | Viable DNA |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow; Extracted DNA | FLT3-ITD (internal tandem duplication) mutation; FLT3-TKD (tyrosine kinase domain) mutation |
| Blood; Bone marrow; RNA | Acute myeloid leukaemia RUNX1; ETV6/RUNX1 gene rearrangement; JAK2 V617F mutation; JAK2 exon 12 mutation; JAK2 exon 14 mutation; KMT2A/AFF1 gene rearragement; RUNX1/RUNX1T1 gene rearrangement; TCF3/PBXI gene rearrangement; inv(16)/t(16;16) CBFB-MYH11 gene rearrangement; t(12;21); t(15;17) PML-RARA gene rearrangement; t(1;19); t(4;11); t(8;21) AML1-EMO gene rearrangement; t(9;22) BCR-ABL gene rearrangement | |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow; Buccal swabs; Extracted DNA; Tissues | Quantitation of donor and recipient bone marrow derived cells in a transplant recipient |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Thalassaemia; Variant haemoglobin; α-Thalassaemia; β-Thalassaemia |
| Molecular genetics - RNA extraction | Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Viable RNA |
| Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow | BCR-ABL kinase domain mutation; Nucleophosmin 1 (NPM1) exon 11; RNA |
Immunopathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Neurofilament light chain |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Serum | C1 esterase inhibitor functional |
| C1 esterase inhibitor | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Biopsy specimens | Anti-tissue antigen antibodies |
| Cerebrospinal fluid (CSF); Serum | Anti-neuronal antibodies | |
| Anti-contactin associated protein (CASPR); Anti-dipeptidyl aminopeptidase-like protein 6 antibodies (DPPX); Anti-gamma aminobutyric acid (GABA) B receptor antibodies; Anti-glutamate receptor antibodies (AMPA/NMDA); Anti-leucine rich glioma inactivated protein 1 antibodies (LGI 1) | ||
| Anti-myelin oligodendrocyte glycoprotein antibodies (MOG) | ||
| Serum | Anti-extractable nuclear antigen antibodies (ENA) | |
| Anti-desmoglein-1 antibodies (DSG-1); Anti-desmoglein-3 antibodies (DSG-3) | ||
| Anti-double stranded DNA antibodies (dsDNA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3) | ||
| Anti-liver antibodies | ||
| Anti-adrenal cortex antibodies | ||
| Anti-N-methyl-D-aspartate receptor antibodies (NMDA); Anti-aquaporin 4 antibodies (AQP4); Anti-contactin associated protein (CASPR); Anti-endomysial antibodies (EMA); Anti-gamma aminobutyric acid (GABA) B receptor antibodies; Anti-glutamate receptor antibodies (AMPA/NMDA); Anti-islet cell antibodies (ICA); Anti-leucine rich glioma inactivated protein 1 antibodies (LGI 1); Anti-neutrophil cytoplasmic antibodies - ANCA IIF; Anti-nuclear antibodies (ANA); Anti-pemphigoid antibodies; Anti-pemphigus antibodies; Anti-skin antibodies; Anti-tissue antigen antibodies | ||
| Anti-heat shock protein 70 antibodies (Hsp70) | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-deamidated gliadin antibodies; Anti-histone antibodies (AHA); Anti-intrinsic factor antibodies (IF); Anti-tissue transglutaminase antibodies (tTG) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Ara h2 - Peanut |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Penicilloyl G; Penicilloyl V |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Cow dander; Dog dander; Feather mix; Horse dander; Sheep epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Codfish; Crab; Lobster; Oyster; Seafood mix; Shrimp; Squid |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Banana; Kiwi; Potato; Tomato |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cow milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Omega-5-gliadin; Staple food mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Cashew nut; Hazelnut; Lupin seed; Macadamia nut; Maize; Nut panel; Oat; Peanut; Pecan nut; Pinenut; Rice; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bermuda grass; Grass mix; Rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Bee venom; Common wasp (yellow jacket) venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Plantain - English |
| Immunopathology - Quantitation of complement proteins | Body fluids; Serum | Total haemolytic complement |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Other body fluids | β2-Transferrin | |
| Plasma; Serum | Albumin; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Detection and quantitation of free kappa and free lambda light chains | ||
| Serum | Monoclonal proteins | |
| Cryoglobulins | ||
| Urine | Detection and amount of paraproteins; Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Immunoglobulin subclasses |
| Serum | Total immunoglobulin E |
Infectious Diseases Ward Clinical Acute Services Building
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
| Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Glucose; Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH | ||
| Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Glucose; Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Maternity Services
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
Microbiology – Antimicrobial Resistance Laboratory (AMR)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Pus; Respiratory specimens; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Antibiotic susceptibility |
| Isolates | Pathogenic identification and antibiotic susceptibility |
Microbiology – Bacterial Identification Laboratory (ID Lab)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; Genital swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Pathogenic identification |
| Aspirates; Bronchoalveolar lavage; Faeces; Fluids; Gastric aspirate; Genital swabs; Urine | Mycoplasma hominis; Ureaplasma spp. | |
| Bacterial isolates | Haemophilus influenzae | |
| Isolates | Bacteria | |
| Pathogenic identification and antibiotic susceptibility | ||
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Isolates | Detection and characterisation of bacteria (including identification and typing) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Amniotic fluid; Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Fluids; Sterile site; Tissues | Pan-bacterial 16s |
| Bacterial isolates | Corynebacterium diphtheriae toxin | |
| Burkholderia cepacia complex | ||
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Bacterial isolates | Viable DNA |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis; DNA sequencing reaction purification step |
Microbiology – Clinical Virology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Pus; Rectal swabs; Tissues | Chlamydia trachomatis serovars L1, L2, L2a or L3 (LGV) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Amniotic fluid; Blood; Breast milk; Cerebrospinal fluid (CSF); Fresh biopsy; Plasma; Urine | Cytomegalovirus (CMV) - Qualitative |
| Amniotic fluid; Plasma; Semen; Serum; Urine | Zika virus | |
| Blood; Bronchoalveolar lavage; Cell culture; Cell lines; Endotrachael aspirate; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Pleural fluid; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF) | Varicella zoster virus (VZV) | |
| Cerebrospinal fluid (CSF); Fresh biopsy; Plasma | Epstein-Barr virus - Quantitative; Epstein-Barr virus | |
| Human herpes virus type 6 (HHV6) | ||
| Cervical specimen; Dry swabs; Fresh biopsy; General swabs; Genital swabs; Skin lesions; Urethral swabs; Vaginal swabs; Vesicle fluid; Vesicle swabs | Varicella zoster virus (VZV) | |
| Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2) | ||
| Eye swabs; Urine | Adenovirus | |
| Fresh biopsy; Lesion swabs | Monkeypox virus | |
| Lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Adenovirus; Enterovirus group; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Picornavirus; Respiratory syncytial virus (RSV); Rhinovirus | |
| Nasal swabs; Nasopharyngeal aspirate; Throat swabs | Human coronavirus MERS ORF1a gene; Human coronavirus MERS UpE gene | |
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nucleic acid; Throat swabs | Influenza A virus H5 | |
| Influenza A virus; Influenza A virus H1; Influenza A virus H1 - 2009 pandemic strain; Influenza A virus H1/09; Influenza A virus H1/H; Influenza A virus H3; Influenza A virus H3N2; Influenza A virus H7 - 2013 China strain; Influenza A virus H7N9 - 2013 China strain | ||
| Plasma | Cytomegalovirus (CMV) - Quantitative | |
| Hepatitis C virus (HCV) viral RNA; Hepatitis C virus (HCV) viral load - Qualitative | ||
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Amniotic fluid; Blood; Bronchoalveolar lavage; Cell culture; Endotrachael aspirate; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Plasma; Pleural fluid; Semen; Serum; Sputum; Urine | DNA storage for future analyses; Purified PCR product; RNA storage for future analyses; Viable DNA; Viable DNA for sequencing; Viable RNA; Viable RNA for sequencing |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis; DNA sequencing reaction purification step |
| Microbiology - Molecular biology - Microbial genotyping | Blood | Cytomegalovirus (CMV); Drug resistance and pre-core and basal core mutations |
| Dry swabs; Nasal swabs; Throat swabs | Measles virus genotyping; Drug resistance Influenza | |
| Plasma | Human immunodeficiency virus (HIV) genotyping for anti-retroviral resistance; Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Hepatitis C virus (HCV) genotyping for anti-retroviral resistance; Hepatitis C virus (HCV) sequencing for antiviral resistance | ||
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load; Human immunodeficiency virus (HIV) RNA viral load |
| Microbiology - Virology - Detection of pathogenic viruses | Aspirates; Biopsy specimens; Blood; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Cervical swabs; Dry swabs; Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital specimens; Isolates; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Operative specimens; Post-operative wounds; Rectal swabs; Respiratory swabs and/or washings; Serum; Skin; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Vesicle fluid | Detection, isolation and characterisation of viruses |
Microbiology – Core Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Pus; Respiratory specimens; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Antibiotic susceptibility; Pathogenic identification; Pathogenic microorganisms |
| Aspirates; Bacterial isolates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Pus; Respiratory specimens; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Pathogenic identification; Pathogenic microorganisms | |
| Antibiotic susceptibility | ||
| Antibiotic susceptibility | ||
| Aspirates; Bacterial isolates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; Genital swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Pathogenic identification | |
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Pus; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Pathogenic microorganisms | |
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; IV catheters; Operative specimens; Oral sites; Pus; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Pathogenic microorganisms | |
| Aspirates; Biopsy specimens; Ear swabs; Eye swabs; Fine needle aspirates (FNA); Fluids; General swabs; Operative specimens; Oral sites; Pus; Respiratory swabs and/or washings; Sputum; Superficial sites; Throat swabs; Tissues; Wound swabs | Pathogenic microorganisms; Quantification of bacteria | |
| Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fine needle aspirates (FNA); Fluids; Gastric aspirate; General swabs; Genital swabs; IV catheters; Intra-uterine contraceptive device (IUCD); Operative specimens; Oral sites; Pus; Respiratory swabs and/or washings; Sputum; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Cerebrospinal fluid (CSF) | Streptococcus pneumoniae antigen | |
| Cerebrospinal fluid (CSF); Fluids; Synovial fluid | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Faeces | Blood; Fat globules; Leucocytes (white blood cells, WBC); Pathogenic microorganisms | |
| Clostridioides difficile toxin | ||
| Genital swabs | Bacteria; Pathogenic microorganisms | |
| Isolates | Pathogenic identification and antibiotic susceptibility | |
| Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Red blood cell morphology | |
| Legionella antigen; Streptococcus pneumoniae | ||
| Bacteria; Pathogenic microorganisms | ||
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air; Blood transfusion bags; Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Spore strips; Vascular catheter tips; Waters | Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Gram negative multi-drug resistant organisms (MRO); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE); Mycobacteria identification; Mycology identification |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Fluids | Acinetobacter baumannii; Enterobacteriaceae; Enterococcus faecalis; Enterococcus faecium; Haemophilus influenzae; Neisseria meningitidis; Pseudomonas aeruginosa; Salmonella spp.; Shigella spp.; Staphylococcus aureus; Staphylococcus epidermidis; Antibiotic resistance gene detection; CarbaA; CarbaA - Imipenem (IMI); CarbaB1; CarbaD; CarbaR; Carbapenemase-producing organisms (CPO); Extended spectrum beta-lactamases (ESBL); MecA gene; MecC gene; Methicillin resistant Staphylococcus aureus (MRSA); Mobilised colistin resistance (MCR-1); Nuc gene; SCCmec-orfX gene junction; Van A/B; pAmpC1; rRNA methyltransferases (16S RMTases) |
| Cerebrospinal fluid (CSF) | Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis; Streptococcus pneumoniae | |
| Endocervical swabs; Liquid based cytology specimens; Urine; Vaginal swabs | Chlamydia trachomatis; Neisseria gonorrhoeae; Trichomonas vaginalis | |
| Faeces; Rectal swabs | Clostridioides difficile; Vancomycin resistant Enterococci (VRE) | |
| Faeces; Sterile site; Wound swabs | Campylobacter spp.; Enterococcus faecalis; Enterococcus faecium; Escherichia coli STEC stx1/stx2; Salmonella spp.; Shigella spp.; Staphylococcus aureus; Antibiotic resistance gene detection; MecA gene; MecA/C gene; MecC gene; Nuc gene; Van A/B | |
| Nasal swabs | Staphylococcus aureus; MecA gene; MecA/C gene; Methicillin resistant Staphylococcus aureus (MRSA); Nuc gene; SCCmec-orfX gene junction | |
| Rectal swabs; Throat swabs | Chlamydia trachomatis; Neisseria gonorrhoeae; Trichomonas vaginalis | |
| Rectal swabs; Vaginal swabs | Streptococcus agalactiae (Streptococcus group B) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Axilla swabs; Groin swabs; Nasal swabs; Perineal swabs | Candida auris |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces; Rectal swabs | Cryptosporidium spp.; Entamoeba histolytica; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Cerebrospinal fluid (CSF); Tissues; Urine | Japanese encephalitis virus (JEV); Kunjin virus; Murray Valley encephalitis virus; West Nile virus |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Oropharyngeal swabs; Sputum; Throat swabs | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Respiratory syncytial virus (RSV) A/B; Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF) | Enterovirus; Human herpes virus (HHV); Human parechovirus; Varicella zoster virus (VZV) | |
| Faeces | Adenovirus; Astrovirus; Norovirus; Rotavirus; Sapovirus | |
| Fresh biopsy; Lesion swabs | Herpes simplex virus (HSV); Monkeypox virus; Varicella zoster virus (VZV) | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
| Nasal swabs; Nasopharyngeal aspirate; Throat swabs; Urine | Measles virus; Measles virus - Vaccine strain | |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs; Oropharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Bacterial isolates | DNA storage for future analyses; Viable DNA |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Aspirates; Biopsy specimens; Blood; Bone marrow; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Gastric lavage; Gastrointestinal fluid; Genital swabs; Intra-uterine contraceptive device (IUCD); Isolates; Lymph node fluid; Operative specimens; Oral sites; Other body fluids; Respiratory specimens; Sputum; Superficial sites; Tissues; Urine; Wound swabs | Mycobacteria detection; Other pathogenic bacteria to genus level or species level |
| Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastrointestinal fluid; General swabs; Other body fluids; Respiratory specimens; Sputum; Tissues | Mycobacteria identification; Other pathogenic bacteria to genus level or species level | |
| Mycobacteria detection; Mycobacteria identification; Other pathogenic bacteria to genus level or species level | ||
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Biopsy specimens; Ear swabs; Eye swabs; Fine needle aspirates (FNA); Fluids; General swabs; Operative specimens; Oral sites; Pus; Respiratory swabs and/or washings; Sputum; Superficial sites; Throat swabs; Tissues; Wound swabs | Pathogenic microorganisms; Quantification of fungi |
| Aspirates; Blood; Bronchial lavage; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Hair; Isolates; Nails; Ocular specimens; Respiratory swabs; Serum; Skin; Skin scrapings; Sputum; Tissues; Urine; Wound swabs | Fungi identification | |
| Fungi identification | ||
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Faeces; Respiratory specimens; Sputum; Urine | Acanthamoeba spp.; Babesia spp.; Cryptosporidia; Cyclospora; Giardia spp.; Isospora spp.; Microfilaria; Microsporidia; Scabies; Schistosoma spp.; Strongyloides stercoralis; Amoebae; Cysts; Malaria; Ova; Parasites; Worms |
| Blood; Bone marrow; Corneal scrapings; Faeces; Vitreous fluid | Acanthamoeba spp.; Leishmania spp.; Strongyloides stercoralis | |
| Faecal swabs; Faeces | Cysts; Ova; Parasites | |
| Genital swabs | Trichomonad |
Microbiology – Core Serology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis A virus (HAV); Hepatitis A virus antibody (anti-HAV) - Total |
| Serum | Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis B virus surface antigen (HBs Ag) neutralisation; Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Syphilis Treponema pallidum antibody; Anti-streptolysin O (ASOT) | |
| Hepatitis D virus (HDV) total antibody |
Microbiology – Emerging Infectious Disease and Biohazard Response unit (EIBRU)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air; Blood transfusion bags; Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Spore strips; Vascular catheter tips; Waters | Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Gram negative multi-drug resistant organisms (MRO); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE); Mycobacteria identification |
| Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Gram negative multi-drug resistant organisms (MRO); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE); Mycobacteria identification; Mycology identification | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Francisella tularensis IgG antibody; Francisella tularensis IgM antibody |
Microbiology – Enteric Reference Laboratory (ERL)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Clostridium perfringens |
| Legionella pneumophila | ||
| Escherichia coli - Shiga toxin-producing (STEC); Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia spp. | ||
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Isolates | Detection and characterisation of bacteria (including identification and typing) |
Microbiology – Molecular Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Amniotic fluid; Aspirates; Cerebrospinal fluid (CSF); Cord blood; Dry swabs; Eye swabs; Fluids; Genital swabs; Paraffin embedded tissue; Placenta; Rectal swabs; Sterile site; Tissues | Treponema pallidum |
| Aspirates; Bacterial isolates; Blood; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Fluids; Pleural fluid; Respiratory specimens; Sputum | Streptococcus pneumoniae | |
| Aspirates; Bronchial washings; Bronchoalveolar lavage; Dry swabs; Fluids; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Respiratory specimens; Sputum; Throat swabs | Bordetella holmesii; Bordetella parapertussis; Bordetella pertussis | |
| Bacterial isolates; Blood; Cerebrospinal fluid (CSF) | Neisseria meningitidis | |
| Bacterial isolates; Bronchial washings; Bronchoalveolar lavage; Sputum | Legionella pneumophila; Legionella pneumophila serogroup 1; Legionella spp. | |
| Blood; Paraffin embedded tissue; Tissues | Bartonella henselae | |
| Bronchial washings; Bronchoalveolar lavage; Culture isolates; Lung biopsy; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs; Tracheal aspirate | Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Cell lines | Mycoplasma spp. | |
| Cerebrospinal fluid (CSF) | Neisseria meningitidis; Streptococcus pneumoniae | |
| Cerebrospinal fluid (CSF); Ocular fluid; Paraffin embedded tissue; Tissues | Tropheryma whipellii | |
| Genital swabs; Rectal swabs; Urine | Mycoplasma genitalium; Macrolide resistant Mycoplasma genitalium | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Amniotic fluid; Aspirates; Blood; Cerebrospinal fluid (CSF); Eye swabs; Fluids; Foetal blood; Paraffin embedded tissue; Sterile site; Tissues; Vitreous specimens | Toxoplasma gondii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Amniotic fluid; Bone marrow; Fresh biopsy; Paraffin embedded tissue; Plasma; Serum; Tissues | Parvovirus B19 |
| Aspirates; Cerebrospinal fluid (CSF); Eye swabs; Fresh biopsy; Plasma; Serum; Tissues | Coxsackie virus; Echovirus; Enterovirus; Enterovirus 71; Poliovirus | |
| Cerebrospinal fluid (CSF) | Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human parechovirus; Varicella zoster virus (VZV) | |
| Cerebrospinal fluid (CSF); Fresh biopsy; Sterile site; Vitreous specimens | Herpes simplex virus (HSV) | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Plasma; Urine | BK virus; BK virus - Quantitative | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Amniotic fluid; Bacterial isolates; Blood; Body fluids; Bone marrow; Breast milk; Bronchial washings; Bronchoalveolar lavage; Cell culture; Cerebrospinal fluid (CSF); Cord blood; Dried blood spots; Dry swabs; Endotrachael aspirate; Eye swabs; Fluids; Foetal blood; Formalin-fixed paraffin-embedded (FFPE) tissues; Genital swabs; Isolates; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular fluid; Placenta; Plasma; Pleural fluid; Products of conception (POC); Pus; Rectal swabs; Respiratory specimens; Semen; Serum; Skin swabs; Sputum; Sterile site; Throat swabs; Tissues; Urine; Vesicle fluid; Vesicle swabs; Vitreous humor | DNA storage for future analyses; RNA storage for future analyses; Viable DNA; Viable RNA |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis; DNA sequencing reaction purification step |
Microbiology – Mycobacterium Reference Laboratory (MRL)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Isolates | Antibiotic susceptibility |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Aspirates; Bacterial isolates; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Paraffin embedded tissue; Respiratory specimens; Sputum; Tissues | Mycobacterium abscessus; Mycobacterium asiaticum; Mycobacterium avium complex (MAC); Mycobacterium chelonae; Mycobacterium chimaera; Mycobacterium gondonae; Mycobacterium intracellulare; Mycobacterium kansasii; Mycobacterium marinum; Mycobacterium spp.; Mycobacterium szulgai; Mycobacterium tuberculosis complex; Mycobacterium ulcerans |
| Bacterial isolates | Mycobacterium spp. | |
| Bacterial isolates; Sputum | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Bacterial isolates | DNA storage for future analyses; Viable DNA |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Aspirates; Biopsy specimens; Blood; Bone marrow; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Gastric lavage; Gastrointestinal fluid; Genital swabs; Intra-uterine contraceptive device (IUCD); Isolates; Lymph node fluid; Operative specimens; Oral sites; Other body fluids; Respiratory specimens; Sputum; Superficial sites; Tissues; Urine; Wound swabs | Mycobacteria detection; Other pathogenic bacteria to genus level or species level |
| Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastrointestinal fluid; General swabs; Other body fluids; Respiratory specimens; Sputum; Tissues | Mycobacteria identification; Other pathogenic bacteria to genus level or species level | |
| Mycobacteria detection; Mycobacteria identification; Other pathogenic bacteria to genus level or species level | ||
| Isolates | Mycobacteria identification; Other pathogenic bacteria to genus level or species level | |
| Mycobacteria identification; Other pathogenic bacteria to genus level or species level | ||
| Mycobacteria antibiotic susceptibility | ||
| Mycobacteria identification; Other pathogenic bacteria to genus level or species level |
Microbiology – Mycology Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Isolates | Antibiotic susceptibility |
| Bacteria | ||
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Isolates | Detection and characterisation of bacteria (including identification and typing) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Essential Sec protein (SecA1); Pan-bacterial 16s |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Fluids; Isolates; Paraffin embedded tissue; Tissues; Vitreous humor | Aspergillus spp. |
| Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Fluids; Fungal isolates; Paraffin embedded tissue; Sterile site; Tissues; Vitreous humor | Cryptococcus gattii; Cryptococcus neoformans | |
| Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Fluids; Paraffin embedded tissue; Sterile site; Tissues; Vitreous humor | Panfungal - Internal transcribed spacer (ITS) | |
| Bronchial washings; Bronchoalveolar lavage; Sputum | Pneumocystis jirovecii | |
| Fungal isolates | Elongation factor genes; Panfungal - Internal transcribed spacer (ITS); Panfungal 28s; β-Tubulin | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis; DNA sequencing reaction purification step |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Bronchial lavage; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Hair; Isolates; Nails; Ocular specimens; Respiratory swabs; Serum; Skin; Skin scrapings; Sputum; Tissues; Urine; Wound swabs | Fungi identification |
| Fungi identification | ||
| Fungi identification | ||
| Bronchial lavage; Cerebrospinal fluid (CSF); Serum | Aspergillus galactomannan antigen | |
| Isolates | Fungi susceptibility |
Microbiology – Parasitology Reference Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (helminth parasites) | Faeces | Strongyloides stercoralis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium spp. |
| Plasmodium falciparum; Plasmodium knowlesi; Plasmodium malariae; Plasmodium ovale curtisi; Plasmodium ovale wallikeri; Plasmodium vivax | ||
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Faeces | DNA storage for future analyses; Viable DNA |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Faeces; Respiratory specimens; Sputum; Urine | Acanthamoeba spp.; Babesia spp.; Cryptosporidia; Cyclospora; Giardia spp.; Isospora spp.; Microfilaria; Microsporidia; Scabies; Schistosoma spp.; Strongyloides stercoralis; Amoebae; Cysts; Malaria; Ova; Parasites; Worms |
| Blood | Malaria | |
| Blood; Bone marrow; Corneal scrapings; Faeces; Vitreous fluid | Acanthamoeba spp.; Leishmania spp.; Strongyloides stercoralis | |
| Faecal swabs; Faeces | Cysts; Ova; Parasites | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Fasciola antibody |
| Leishmaniasis IgG antibody |
Microbiology – Pathogen Genomics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Bioinformatic analysis | DNA sequences; RNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Primary analysis - Quality analysis of primary FASTQ or FASTA file (including assembly and mapping of reads to identified references).; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids by whole genome sequencing | Bacterial isolates; Microbial nucleic acids | Microbial identification; Resistance; Virulence |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Amniotic fluid; Blood; Body fluids; Bone; Bone marrow; Dry swabs; Faeces; Isolates; Plasma; Products of conception (POC); Saliva; Serum; Tissues; Urine | DNA storage for future analyses; RNA storage for future analyses; Viable DNA; Viable DNA for sequencing; Viable RNA; Viable RNA for sequencing |
| Bacterial isolates | DNA storage for future analyses; Viable DNA; Viable DNA for sequencing | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Extracted DNA; Extracted RNA | DNA sequence analysis; DNA sequencing reaction purification step; RNA sequence analysis; Sequenced DNA utilising massively parallel sequencing technologies |
| Microbiology - Molecular biology - Microbial genotyping | Isolates | Drug resistance Mycobacterium tuberculosis |
| Drug resistance Klebsiella pneumoniae | ||
| Mycobacterium tuberculosis | ||
| Drug resistance Escherichia coli | ||
| Microbiology - Molecular biology - Public health investigation and/or monitoring | Bronchial washings; Bronchoalveolar lavage; Isolates; Nasopharyngeal swabs; Sputum; Throat swabs | Phylogenetic analysis |
| Isolates | Detection and characterisation of organisms (including identification and typing); Organism characterisation for patient management; Phylogenetic analysis |
Microbiology – Pneumococcal Reference Laboratory (PRL)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Streptococcus pneumoniae; Streptococcus pneumoniae antigen; Streptococcus pneumoniae capsular antigen |
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Isolates | Detection and characterisation of bacteria (including identification and typing) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Eye swabs; Fluids; Fresh biopsy; Pleural fluid | Streptococcus pneumoniae; Streptococcus pneumoniae cpsA gene; Streptococcus pneumoniae cpsB gene |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Bacterial isolates | Viable DNA |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | DNA sequence analysis; DNA sequencing reaction purification step |
Microbiology – Serology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
Suspended Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Leptospira spp. |
| Microbiology - Mycobacteriology - Tests for cell mediated immunity | Blood | Interferon-γ (IFN-γ) release assays |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cerebrospinal fluid (CSF) | Zika virus IgM antibody |
| Cerebrospinal fluid (CSF); Serum | Dengue virus 1 IgM antibody; Dengue virus 2 IgM antibody; Dengue virus 3 IgM antibody; Dengue virus 4 IgM antibody; Dengue virus IgM antibody; Dengue virus group specific IgM antibody | |
| Barmah forest virus IgM antibody | ||
| Chikungunya virus IgM antibody | ||
| Kunjin virus IgM antibody | ||
| Sindbis virus IgM antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Alfuy virus (ALFV) IgM antibody; Edge Hill virus IgM antibody; Flavivirus IgM; Flavivirus screen; Kokobera virus IgM antibody; Stratford virus IgM antibody; West Nile virus IgM antibody - NY99 strain; West Nile virus IgM antibody - Sarafend strain; Yellow fever virus; Yellow fever virus IgM antibody | ||
| Alphavirus IgM antibody; Getah virus IgM antibody | ||
| Ross River virus IgM antibody | ||
| Murray Valley encephalitis virus IgM antibody | ||
| Bunyaviridae spp.; Gan Gan virus IgM antibody; Trubanaman virus IgM antibody | ||
| Japanese encephalitis virus (JEV) IgM antibody | ||
| Plasma; Serum | Measles IgM antibody; Mumps virus IgM antibody | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) total antibody | ||
| Measles IgG antibody; Mumps virus IgG antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgA antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody | ||
| Serum | Dengue virus 1 total antibody; Dengue virus 2 total antibody; Dengue virus 3 total antibody; Dengue virus 4 total antibody; Dengue virus group specific total antibody | |
| Bartonella henselae total antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Coccidioides spp.; Histoplasma spp. | ||
| Fluorescent Treponemal antibody | ||
| Legionella longbeachae; Legionella longbeachae antibody; Legionella pneumophila serogroup 1 antibody; Legionella pneumophila serogroup 2 antibody; Legionella pneumophila serogroup 3 antibody; Legionella pneumophila serogroup 4 antibody; Legionella pneumophila serogroup 5 antibody; Legionella pneumophila serogroup 6 antibody; Legionella pneumophila total antibody; Legionella spp. | ||
| Brucella IgG antibody; Brucella IgM antibody | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Ross River virus total antibody | ||
| Gan Gan virus total antibody; Trubanaman virus total antibody | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Kunjin virus; Kunjin virus specific total antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Bunyaviridae spp.; Gan Gan virus IgG antibody; Trubanaman virus IgG antibody | ||
| Murray Valley encephalitis virus specific total antibody | ||
| Sindbis virus IgG antibody; Sindbis virus total antibody | ||
| Rabies virus | ||
| Coxiella burnetii (Q-fever) IgA phase 1 antibody; Coxiella burnetii (Q-fever) IgA phase 2 antibody; Coxiella burnetii (Q-fever) IgG phase 1 antibody; Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 1 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Cytomegalovirus (CMV) IgG avidity; Epstein-Barr virus nuclear antigen; Rubella IgM antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody; Toxoplasma avidity | ||
| Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG | ||
| Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus (HIV) p24 antigen | ||
| Lyme IgG antibody | ||
| Influenza B virus IgG antibody; Influenza B virus IgM antibody | ||
| Chikungunya virus; Chikungunya virus IgG antibody; Chikungunya virus total antibody | ||
| Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody | ||
| Dengue virus NS1 antigen | ||
| Herpes simplex virus (HSV) IgM | ||
| Hepatitis E virus (HEV) IgG; Hepatitis E virus (HEV) IgM | ||
| Syphilis Treponema pallidum IgM antibody | ||
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM | ||
| Chlamydia trachomatis IgG antibody | ||
| Japanese encephalitis virus (JEV) total antibody | ||
| Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody | ||
| Rickettsia australis; Rickettsia spp.; Rickettsia tsutsugamushi antibody; Rickettsia typhi | ||
| Barmah forest virus IgG antibody | ||
| Angiostrongylus cantonensis antibody; Filaria IgG antibody; Schistosoma mansoni IgG antibody; Schistosoma spp. IgG antibody; Strongyloides IgG antibody | ||
| Zika virus IgG antibody; Zika virus IgM antibody | ||
| Getah virus total antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Chikungunya virus IgM antibody | ||
| Japanese encephalitis virus (JEV) IgG antibody | ||
| Hydatid IgG | ||
| Taenia solium; Trichinella spp. antibody | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Alphavirus IgG antibody; Getah virus IgG antibody | ||
| Varicella zoster virus IgM antibody | ||
| Ross River virus IgG antibody | ||
| Entamoeba histolytica | ||
| Epstein-Barr virus early antigen IgG antibody; Epstein-Barr virus early antigen diffuse IgG antibody; Epstein-Barr virus early antigen restricted IgG antibody | ||
| Chlamydial spp. IgG antibody | ||
| Helicobacter pylori IgG antibody | ||
| Flavivirus IgG; Flavivirus group specific total antibody; Flavivirus screen | ||
| Leptospira IgG antibody; Leptospira IgM antibody | ||
| Adenovirus IgG antibody | ||
| Varicella zoster virus (VZV) IgG antibody | ||
| Adenovirus IgM antibody | ||
| Trypanosoma cruzi | ||
| Alfuy virus (ALFV) IgG antibody; Alfuy virus (ALFV) total antibody; Edge Hill virus IgG antibody; Edge Hill virus total antibody; Kokobera virus IgG antibody; Kokobera virus total antibody; Stratford virus IgG antibody; Stratford virus total antibody; West Nile virus IgG antibody - NY99 strain; West Nile virus IgG antibody - Sarafend strain; West Nile virus total antibody - NY99 strain; West Nile virus total antibody - Sarafend strain; Yellow fever virus; Yellow fever virus IgG antibody; Yellow fever virus total antibody | ||
| Flavivirus IgG | ||
| Lyme IgG antibody | ||
| Monkeypox virus IgG antibody; Monkeypox virus IgM antibody; Orthopox virus group; Vaccinia virus IgG antibody; Vaccinia virus IgM antibody | ||
| Dengue virus 1 IgG antibody; Dengue virus 2 IgG antibody; Dengue virus 3 IgG antibody; Dengue virus IgG antibody | ||
| Coxiella burnetii (Q-fever) IgG phase 2 antibody | ||
| Human herpes virus type 6 (HHV6) IgG antibody; Human herpes virus type 6 (HHV6) IgM antibody | ||
| Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Bordetella pertussis IgA | ||
| Influenza A virus IgG antibody; Influenza A virus IgM antibody | ||
| Barmah forest virus total antibody | ||
| Toxocara spp. IgG antibody | ||
| Mycoplasma pneumoniae IgM antibody | ||
| Coxiella burnetii (Q-fever) IgG phase 1 antibody | ||
| Zika virus total antibody |
Operating Theatre – Clinical Acute Services Building
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
| Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin F (HbF); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total haemoglobin - Calculated; pH |
Pre-Admissions Clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Tissue Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
12 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Endometrial pipelle; Vaginal smears; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Immunocytochemical investigation (on non-paraffin embedded cellular preparations) | Fixed cytological smears | Detection of antigenic targets - Various |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Semen; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Fluids; Formalin-fixed tissue; Gluteraldehyde tissue; Nasal brushings | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Smears; Tissue imprint | Intra-operative consultation and examination of biopsy material; Rapid onsite evaluation (ROSE) |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2154
Site No.
2147
Print date
15 Dec 2024
END OF SCOPE